Mizagliflozin for low blood sugar after weight-loss surgery
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests a medication called mizagliflozin to see if it can reduce episodes of low blood sugar in people who have had gastric bypass surgery. If you experience symptoms like confusion or fainting when your blood sugar drops, this study might help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and had Roux-en-Y gastric bypass surgery more than a year ago.
- You have had symptoms of low blood sugar (like confusion, seizures, or loss of consciousness) that go away when you eat or drink something sugary, and your blood sugar was below 54 mg/dL during these episodes.
- You have had at least 4 low blood sugar episodes during a 3-week monitoring period before the study starts.
- You are not currently taking insulin or certain diabetes medications that increase insulin (like sulfonylureas).
- You are not currently taking GLP-1 agonists or similar drugs (unless you have stopped them for a wash-out period).
- You do not have certain heart conditions, recent heart attack, stroke, or active cancer, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cortisol affects blood sugar drops after weight-loss surgery. It may help explain links between cortisol, obesity, and low blood sugar episodes.
This trial tests whether a diabetes medication called dapagliflozin helps smooth out blood sugar swings after bariatric (weight-loss) surgery. It may help people with type 2 diabetes achieve better control after their surgery.
This study looks at how the body handles carbohydrates after eating in people who have had gastric bypass surgery, with or without post-surgery hypoglycemia (low blood sugar). The goal is to understand why some people get low blood sugar after meals and how to better manage it.
This trial tests whether a new way of using glucose monitoring can help manage low blood sugar that happens after meals in people who have had gastric bypass surgery. It aims to find better ways to track and treat these episodes.
This study looks at how the hormone glucagon affects blood sugar in people who have had gastric bypass or sleeve gastrectomy surgery more than a year ago, compared to people who have not had any gastrointestinal surgery. It aims to understand glucose metabolism better and may help improve care for people after bariatric surgery.
This study looks at how food moves through the body and how that may affect episodes of low blood sugar caused by too much insulin. It may help researchers better understand and possibly improve care for people who get hypoglycemia, especially after bariatric (weight-loss) surgery.
Hear when a new Postbariatric Hypoglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.